NEW YORK, May 30, 2025 /PRNewswire/ --Why: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of securities of Organon & Co. (NYSE: OGN) between October 31, 2024 and April 30, 2025, both dates inclusive (the "Class Period"). A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than July 22, 2025.So what: If you purchased Organon securities during the Class Period you may ...

NEW YORK, May 30, 2025 (GLOBE NEWSWIRE) -- Wolf Haldenstein Adler Freeman & Herz LLP announces that a securities class action lawsuit has been filed against Organon & Co. (NYSE: OGN) in the United States District Court for the District of New Jersey. Investors who acquired Organon shares during the class period are encouraged to contact the law firm before the lead plaintiff motion deadline on July 22, 2025. PLEASE CLICK HERE TO JOIN THE CASE AND SUBMIT CONTACT INFORMATION Class Action Details Defendant: Or ...

PHILADELPHIA, May 30, 2025 (GLOBE NEWSWIRE) -- Berger Montague PC advises investors that a securities class action lawsuit has been filed against Organon & Co. (“Organon” or the “Company”) (NYSE: OGN) on behalf of purchasers of Organon securities between October 31, 2024 through April 30, 2025, inclusive (the “Class Period”). Investor Deadline: Investors who purchased or acquired Organon securities during the Class Period may, no later than JULY 22, 2025, seek to be appointed as a lead plaintiff representat ...

NEW YORK, May 30, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Organon & Co. ("Organon" or the "Company") (NYSE: OGN) of a class action securities lawsuit.CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Organon investors who were adversely affected by alleged securities fraud between October 31, 2024 and April 30, 2025. Follow the link below to get more information and be contacted by a member of our team:https://zlk.com/pslra-1/organon-co-lawsuit-submission-form?prid= ...

集体诉讼案件 - 罗森律师事务所宣布代表在2024年10月31日至2025年4月30日期间购买Organon证券的投资者提起集体诉讼 [1] - 诉讼指控被告在向投资者提供过于积极陈述的同时 传播了重大虚假和误导性声明 并隐瞒了与资本配置相关的重大不利事实 [5] - 被告隐瞒了收购Dermavant后公司债务削减策略的高优先级 导致季度股息减少70% [5] 律师事务所背景 - 罗森律师事务所专注于证券集体诉讼和股东衍生诉讼 在全球范围内代表投资者 [4] - 该律所曾创下针对中国公司的最大证券集体诉讼和解记录 [4] - 2017年被ISS证券集体诉讼服务评为和解数量第一 2013年以来每年排名前四 [4] - 2019年为投资者追回超过4.38亿美元 累计为投资者追回数亿美元 [4] 投资者参与方式 - 投资者可在2025年7月22日前申请担任首席原告 [1][3] - 参与方式包括访问特定网址或联系Phillip Kim律师 [3][6] - 投资者可选择保留自己的律师或保持缺席成员身份 [7]

NEW YORK, May 29, 2025 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders of Organon & Co. (NYSE: OGN). Shareholders who purchased shares of OGN during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery. CONTACT US HERE: https://securitiesclasslaw.com/securities/organon-co-loss-submission-form/?id=150529&from=3 CLASS PERIOD: October 31, 2024 to April ...

公司动态 - Organon因证券集体诉讼被起诉 涉及2024年10月31日至2025年4月30日期间购买其证券的投资者 [1] - Organon总部位于新泽西州泽西市 专注于女性健康领域 2024年10月以12亿美元收购皮肤病生物制药公司Dermavant [2] 诉讼指控 - 公司被指控在收购Dermavant后增加债务的同时 仍向投资者保证维持股息分配 并将其列为"第一资本配置优先事项" [3] - 诉讼称公司实际已改变资本配置优先级 转向专注于债务削减 [3] 财务变动 - 2025年5月1日 Organon宣布将每股股息从0.28美元大幅下调至0.02美元 [4] - 公司管理层解释称重置资本配置优先级是为了加速去杠杆化进程 目前向股东返还资本已不再是优先事项 [4] 市场反应 - 股息下调消息导致股价单日下跌3.48美元 跌幅达27% 从4月30日收盘价12.93美元跌至5月1日9.45美元 [4] 投资者权利 - 投资者可在2025年7月22日前申请成为首席原告代表 [2] - 首席原告通常是在拟议投资者类别中具有最大财务利益且具有代表性的个人或小组投资者 [5]

NEW YORK, May 29, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Organon & Co. (NYSE: OGN) and certain of the Company’s senior executives for potential violations of the federal securities laws. If you invested in Organon you are encouraged to obtain additional information by visiting https://www.bfalaw.com/cases-investigations/organon-co-class-action. Investors have until July 22, 2025, to ask the Court to be appointed to lead ...

NEW YORK, May 29, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Organon & Co. (NYSE: OGN).Shareholders who purchased shares of OGN during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery.CONTACT US HERE:https://securitiesclasslaw.com/securities/organon-co-loss-submission-form/?id=150510&from=4CLASS PERIOD: October 31, 2024 to April 30, 202 ...

诉讼案件 - 投资者可在2025年7月22日前对Organon & Co提起证券集体诉讼 涉及2024年10月31日至2025年4月30日期间购买该公司证券的投资者 [1] - 诉讼指控Organon及部分高管在特定期间未披露重大信息 违反联邦证券法 [3] - 案件名称为Hauser V Organon & Co 案件编号25-cv-05322 由新泽西州联邦地区法院受理 [1][5] 公司财务变动 - 2025年3月10日盘前 公司公布2025年第一季度财报 宣布将季度股息从0.28美元大幅下调至0.02美元 [4] - 股息政策调整与公司先前关于"维持季度股息为优先事项"的承诺相矛盾 [4] - 该公告导致股价在2025年4月30日至5月1日期间从12.93美元暴跌27%至9.45美元 [4] 投资者服务 - ClaimsFiler提供免费股东信息服务 协助零售投资者参与证券集体诉讼索赔 [6] - 投资者可通过网站注册获取证券集体诉讼案件信息 上传投资组合数据以接收相关案件通知 [6] - 法律咨询由Kahn Swick & Foti LLC律师事务所提供 包括免费案件评估服务 [2][6]